Roundtable Roundup: Treatment for Metastatic pMMR Endometrial Cancer

Publication
Article
Peers & Perspectives in OncologyJuly 2024
Pages: 68

In separate, live virtual events, Michael J. Birrer, MD, PhD, and Jubilee Brown, MD, surveyed participants on the treatment of a postmenopausal woman with stage IVA endometrial cancer after first-line chemotherapy.

case summary-endometrial
event region map-roundup
roundup 2
timing poll: roundup 3
Download Issue PDF
Articles in this issue
Leon-Ferre Explores Targeting of PIK3CA Alterations in ER+ Breast Cancer
Leon-Ferre Explores Targeting of PIK3CA Alterations in ER+ Breast Cancer
Roundtable Roundup: Treatment for Metastatic pMMR Endometrial Cancer
Roundtable Roundup: Treatment for Metastatic pMMR Endometrial Cancer
Khouri Discusses Selinexor Dosing and Management Approaches for R/R MM
Khouri Discusses Selinexor Dosing and Management Approaches for R/R MM
George Explores Impact of Risk Status With Cabozantinib/Nivolumab in Advanced RCC
George Explores Impact of Risk Status With Cabozantinib/Nivolumab in Advanced RCC
Depth of Response With Quadruplet Regimens Considered in Newly Diagnosed Multiple Myeloma
Depth of Response With Quadruplet Regimens Considered in Newly Diagnosed Multiple Myeloma
Rossetti Reviews Myelofibrosis Risk Stratification and Outcome Data for Pacritinib
Rossetti Reviews Myelofibrosis Risk Stratification and Outcome Data for Pacritinib
Practice Updates in Lung Cancer Stem From Biomarker Testing and Up-Front Immunotherapy
Practice Updates in Lung Cancer Stem From Biomarker Testing and Up-Front Immunotherapy
Bardia Analyzes Treatment for Certain Patients With Advanced Breast Cancer
Bardia Analyzes Treatment for Certain Patients With Advanced Breast Cancer
Immunotherapy’s Survival Benefit Opens New Doors in the Adjuvant RCC Setting
Immunotherapy’s Survival Benefit Opens New Doors in the Adjuvant RCC Setting
Recent Videos
Related Content
Lenvatinib and Pembrolizumab Combo Breaks New Ground in Non–Clear Cell RCC

Lenvatinib and Pembrolizumab Combo Breaks New Ground in Non–Clear Cell RCC

Morgan Bayer
September 6th 2024
Article

There are remaining gaps in papillary renal cell carcinoma that data from 3 pending trials hope to fill.

Read More

Pushing Forward With Molecularly-Driven Precision Medicine in Endometrial Cancer

Pushing Forward With Molecularly-Driven Precision Medicine in Endometrial Cancer

Nichole Tucker;Ruchi Garg, MD
June 23rd 2023
Podcast

In season 4, episode 8 of Targeted Talks, Ruchi Garg, MD, discusses treatment approaches for endometrial cancer now and in the near future.

Listen

Positive Responses Are Reported for Fianlimab/Cemiplimab in ccRCC

Positive Responses Are Reported for Fianlimab/Cemiplimab in ccRCC

Chris Ryan
September 4th 2024
Article

Fianlimab plus cemiplimab was well-tolerated and showed durable responses, in pretreated patients with advanced clear cell renal carcinoma.

Read More

The Evolution of Endometrial Cancer Treatment

The Evolution of Endometrial Cancer Treatment

Nichole Tucker
August 15th 2022
Podcast

In season 3, episode 7 of Targeted Talks, John Nakayama, MD, discusses updates in the endometrial cancer treatment landscape.

Listen

Technology Drives Biomarker Testing Rates in Precision Oncology

Technology Drives Biomarker Testing Rates in Precision Oncology

Erin Crum, MPH;Regina Murphy, MBA
August 30th 2024
Article

The knowledge gained from biomarker testing can help develop cancer prevention, diagnosis, and treatment strategies that specifically target a person’s cancer subtype.

Read More

The Promise of Gene Editing in Cancer Approaches Fruition

The Promise of Gene Editing in Cancer Approaches Fruition

John M. Burke, MD
August 29th 2024
Article

As gene editing technology continues to advance, it could fundamentally change the landscape of cancer treatment.

Read More